Cite
HARVARD Citation
Shouse, G. et al. (n.d.). MDS AS A CAUSE FOR PROLONGED HEMATOLOGIC TOXICITY AFTER TREATMENT WITH CD19 TARGETED CAR‐T CELL THERAPY IN PATIENTS WITH RELAPSED REFRACTORY LYMPHOMA. Hematological oncology. pp. 507-508. [Online].